PAGE 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 1997 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period _______________ TO ____________________ Commission file number 1-44 ARCHER-DANIELS-MIDLAND COMPANY (Exact name of registrant as specified in its charter) Delaware 41-0129150 (State or other jurisdiction of (I. R. S. Employer incorporation or organization) Identification No.) 4666 Faries Parkway Box 1470 Decatur, Illinois 62525 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code217-424-5200 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes __X__ No . Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Common Stock, no par value - 533,417,633 shares (April 30, 1997) 1 PAGE 2 PART I - FINANCIAL INFORMATION ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) THREE MONTHS ENDED MARCH 31, 1997 1996 ----------------------- (In thousands, except per share amounts) Net sales and other operating income $3,465,955 $3,486,665 Cost of products sold and other operating costs 3,254,675 3,147,794 _________ _________ Gross Profit 211,280 338,871 Selling, general and administrative 114,674 120,959 expenses _________ _________ Earnings From Operations 96,606 217,912 Other income (expense) (3,928) 29,489 _________ _________ Earnings Before Income Taxes 92,678 247,401 Income taxes 31,511 84,116 _________ _________ Net Earnings $ 61,167 $ 163,285 ========= ========= Average number of shares outstanding 541,331 546,852 Net earnings per common share $.11 $.30 Dividends per common share $.05 $.048 See notes to consolidated financial statements. 2 PAGE 3 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited) NINE MONTHS ENDED MARCH 31, 1997 1996 ----------------------- (In thousands, except per share amounts) Net sales and other operating income $10,403,401 $10,022,461 Cost of products sold and other operating costs 9,445,739 8,962,407 _________ _________ Gross Profit 957,662 1,060,054 Selling, general and administrative 529,986 348,199 expenses _________ _________ Earnings From Operations 427,676 711,855 Other income 30,899 125,050 _________ _________ Earnings Before Income Taxes 458,575 836,905 Income taxes 203,914 284,548 _________ _________ Net Earnings $ 254,661 $ 552,357 ========= ========= Average number of shares outstanding 543,509 551,505 Net earnings per common share $.47 $1.00 Dividends per common share $.148 $.119 See notes to consolidated financial statements. 3 PAGE 4 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Unaudited) MARCH 31, JUNE 30, 1997 1996 ------------------------- (In thousands) ASSETS Current Assets Cash and cash equivalents $ 632,549 $ 534,702 Marketable securities 230,668 820,147 Receivables 1,356,393 1,131,591 Inventories 2,463,801 1,790,636 Prepaid expenses 130,666 107,607 __________ _________ Total Current Assets 4,814,077 4,384,683 Investments and Other Assets Investments in and advances to 1,043,082 624,305 affiliates Long-term marketable securities 921,334 1,092,969 Other assets 229,383 233,611 __________ __________ 2,193,799 1,950,885 Property, Plant and Equipment Land 117,553 114,542 Buildings 1,388,802 1,245,662 Machinery and equipment 6,693,832 6,034,979 Construction in progress 798,962 588,711 Less allowances for depreciation (4,372,814) (3,869,593) __________ _________ 4,626,335 4,114,301 ___________ ___________ $11,634,211 $10,449,869 ========== =========== See notes to consolidated financial statements. 4 PAGE 5 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (Unaudited) MARCH 31, JUNE 30, 1997 1996 ---------------------- (In thousands) LIABILITIES AND SHAREHOLDERS' EQUITY Current Liabilities Short-term debt $ 765,847 $ - Accounts payable 1,103,225 993,403 Accrued expenses 612,861 525,626 Current maturities of long-term debt 125,231 114,522 __________ __________ Total Current Liabilities 2,607,164 1,633,551 Long-Term Debt 2,327,931 2,002,979 Deferred Credits Income taxes 564,340 562,362 Other 110,196 106,165 __________ __________ 674,536 668,527 Shareholders' Equity Common stock 3,702,008 3,869,875 Reinvested earnings 2,322,572 2,274,937 __________ __________ 6,024,580 6,144,812 __________ __________ 11,634,211 $10,449,869 ========== ========== See notes to consolidated financial statements. 5 PAGE 6 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) NINE MONTHS ENDED MARCH, 31 1997 1996 ---------------------- (In thousands) Operating Activities Net earnings $ 254,661 $ 552,357 Adjustments to reconcile to net cash provided by operations Depreciation and amortization 325,576 288,814 Deferred income taxes (18,961) 62,448 Amortization of long-term debt discount 21,407 18,864 (Gain)loss on marketable securities (59,549) (87,637) transactions Other 4,563 (34,023) Changes in operating assets and liabilities Receivables (21,122) (178,385) Inventories (350,611) (643,295) Prepaid expenses (17,609) 236 Accounts payable and accrued expenses (25,798) 307,195 ________ ________ Total Operating Activities 112,557 286,574 Investing Activities Purchases of property, plant and equipment (590,476) (522,383) Business acquisitions (332,178) (27,904) Investments in and advances to affiliates (387,909) (61,147) Purchases of marketable securities (781,811) (514,610) Proceeds from sales of marketable securities 1,511,897 1,150,881 Other - (1,241) ________ ________ Total Investing Activities (580,477) 23,596 Financing Activities Long-term debt borrowings 347,855 15,093 Long-term debt payments (21,364) (15,084) Net borrowings under line of credit agreements 516,272 89,292 Purchases of treasury stock (198,498) (224,099) Cash dividends and other (78,498) (59,745) ________ ________ Total Financing Activities 565,767 (194,543) ________ ________ Increase In Cash and Cash Equivalents 97,847 115,627 Cash and Cash Equivalents Beginning of 534,702 454,593 Period ________ ________ Cash and Cash Equivalents End of Period $ 632,549 $ 570,220 ======== ======== See notes to consolidated financial statements. 6 PAGE 7 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 1.The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the quarter and nine months ended March 31, 1997 are not necessarily indicative of the results that may be expected for the year ending June 30, 1997. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the year ended June 30, 1996. In February 1997, the Financial Accounting Standards Board issued Statement No. 128, "Earnings Per Share." This statement establishes standards for computing and presenting basic and diluted earnings per share (EPS) for financial statements issued for periods ending after December 15, 1997. The adoption of this statement will not have a material effect on the Company's reported EPS. Note 2. Other Income (Expense) <CAPTI0N> THREE MONTHS ENDED NINE MONTHS ENDED MARCH 31, MARCH 31, 1997 1996 1997 1996 ------------- -------------- (In thousands) (In thousands) Investment income $30,045 $38,292 $ 99,260 $117,443 Interest expense (48,502) (44,024) (142,762)(126,657) Gain (loss) on marketable securities transactions 11,282 19,929 59,566 87,798 Equity in earnings of 4,853 13,315 16,528 26,658 affiliates Other (1,606) 1,977 (1,693) 19,808 ----- ------ ------ ------- $(3,928) $29,489 $30,899 $125,050 ===== ====== ====== ======= Note 3. Per Share Data All references to share and per share information have been adjusted for the 5 percent stock dividend paid September 16, 1996. 7 PAGE 8 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Note 4.Antitrust Investigation and Related Litigation A federal grand jury in the Northern District of Illinois has been conducting an investigation into possible violations by the Company of federal antitrust laws and related matters with respect to the sale of lysine, an amino acid feed additive used in poultry and swine feed. A federal grand jury in the Northern District of California has been investigating possible antitrust violations by the Company with respect to the sale of citric acid, an organic acid used in various foods, beverages and other products. A federal grand jury in the Northern District of Georgia has been investigating possible antitrust violations by the Company with respect to the sale of the Company's high fructose corn syrup product line. Each of these investigations has been under the direction of the United States Department of Justice. Two former executive officers of the Company, Michael D. Andreas and Terrance S. Wilson, have been indicted in connection with the lysine investigation. On October 15, 1996, the Company pled guilty to a two count information in the Northern District of Illinois pursuant to an agreement with the Department of Justice. This information states that the Company engaged in anticompetitive conduct in connection with the sale of lysine and citric acid. In connection with its agreement, the Company has paid the United States a fine of $70 million with respect to lysine and $30 million with respect to citric acid. This agreement constitutes a global resolution of all matters between the United States Department of Justice and the Company and brings to a close all Department of Justice investigations of the Company, including the federal grand jury's investigation with respect to high fructose corn syrup. Following public announcement in June 1995 of these investigations, the Company and certain of its then current directors and executive officers were named as defendants in a number of putative class action suits for alleged violations of federal securities laws on behalf of all purchasers of securities of the Company during the period between certain dates in 1992 and 1995. The Company, along with other domestic and foreign companies, has been named as a defendant in a number of putative class action antitrust suits and other proceedings involving the sale of lysine, citric acid, and high fructose corn syrup. The plaintiffs generally request unspecified compensatory damages, costs, expenses and unspecified relief. The Company and the individuals named as defendants intend to vigorously defend these class actions and proceedings unless they can be settled on terms deemed acceptable by the parties. These matters have resulted, as discussed below, and could result in the Company being subject to monetary damages, other sanctions and expenses. 8 PAGE 9 On July 20, 1996 Federal District Court Judge Milton Shadur approved a settlement in the federal lysine class action antitrust suit filed in the Northern District of Illinois (consolidated as In Re Amino Acid Lysine Antitrust Litigation MDL No. 1083) and the Company has paid $25 million in full settlement thereof without admitting the alleged violations of law. Several plaintiffs opted out of this settlement and numerous state class action antitrust cases involving the sale of lysine remain pending. A non-class action federal antitrust suit involving the sale of lysine which was filed in November 1995 and encaptioned Purina Mills, Inc. et al. v. Archer-Daniels-Midland Co. was subsequently consolidated with In Re Amino Acid Lysine Antitrust Litigation and the Company settled this action, including plaintiffs who opted out of or objected to the settlement noted above, for an amount deemed not material. On September 27, 1996, the Company entered into an agreement with counsel for the plaintiff class in the consolidated federal securities class action suit pending in the Central District of Illinois (G.M. Lawrence Limited Frozen Retirement Trust Dated September 1, 1992, et al. v. Archer-Daniels-Midland Co., et al., Case Number 95-2287) in which among other things, the Company agreed to pay $30 million to members of the class without admitting the alleged violations of law. On April 11, 1997, the court granted final approval of this settlement. On September 27, 1996, the Company entered into an agreement with counsel for the plaintiff class in the consolidated federal citric acid class action antitrust suit filed in the Northern District of California (consolidated as In Re Citric Acid Antitrust Litigation, MDL No. 1092, Marten File No. C-95-2963 (FMS)) in which among other things, the Company agreed to pay $35 million to members of the class without admitting the alleged violations of law. On March 3, 1997, the court preliminarily approved the settlement and the final approval hearing is set for July 21, 1997. Under the terms of the settlement agreement, the Company has the right to rescind the agreement if plaintiffs elect to opt out of the class and those plaintiffs have combined citric acid purchases from the Company during the class period that exceed 25% of the Company's total citric acid sales during such period. Based on the opt out notices that the Company is aware of to date, the Company may, at its option, rescind the settlement agreement on or before May 19, 1997. The Company has also entered into settlement agreements relating to certain state actions filed by indirect purchasers of lysine in which, among other things, the Company has agreed to pay amounts deemed not material to certain members of the class without admitting the alleged violations of law. The Company made a $200 million provision in the quarter ended September 30, 1996 to cover the fines, litigation settlements and related costs and expenses described above. Such provision is reflected in the Company's first quarter selling, general and administrative expenses. Because of the early stage of other putative class actions and proceedings, including those related to high fructose corn syrup, the ultimate outcome and materiality of these matters cannot presently be determined. Accordingly, no provision for any liability that may result therefrom has been made in the unaudited consolidated financial statements. The Company and its directors also have been named as defendants in two putative class action suits, one of which alleges violations of Delaware state law and a similar case in District Court in Illinois which alleges violations of federal securities laws. Both cases seek invalidation of the election of the Company's directors on the basis of alleged omissions from the proxy statement issued by the Company prior to its 1995 Annual Meeting of Shareholders. The case relating to violations of Delaware law has been dismissed and is now on appeal in the Supreme Court of Delaware. 9 PAGE 10 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) The case filed in Federal District Court in Illinois has likewise been dismissed and the Seventh Circuit Court of Appeals has recently dismissed an appeal. Shareholder derivative actions also have been filed against certain of the Company's directors and executive officers and nominally against the Company alleging that the individuals named as defendants breached their fiduciary duties to the Company and seeking monetary damages and other relief on behalf of the Company from the individuals named as defendants. The Company has moved to dismiss these derivative actions on the ground that they cannot be maintained unless the plaintiffs first brought their complaints to the Company's Board of Directors, which they did not. The Company from time to time, in the ordinary course of business, is named as a defendant in various other lawsuits. In the Company's opinion, the gross liability from such other lawsuits, including environmental exposure, with or without insurance recoveries is not considered to be material to the Company's consolidated financial condition or results of operations. 10 PAGE 11 ARCHER DANIELS MIDLAND COMPANY AND SUBSIDIARIES MANAGEMENT'S DISCUSSION OF OPERATIONS AND FINANCIAL CONDITION The Company is in one business segment - procuring, transporting, storing, processing and merchandising agricultural commodities and products. The availability and price of agricultural commodities are subject to wide fluctuations due to unpredictable factors such as: weather; plantings; government (domestic and foreign) farm programs and policies; changes in global demand created by population growth and higher standards of living; and global production of similar and competitive crops. Generally, changes in the price of agricultural commodities can be passed through to the price of processed products. Ethanol is one of a limited few of the Company's processed products which must be priced to compete with products produced from other raw materials. To reduce the price risk of market fluctuations, the Company follows a policy of hedging substantially all inventory and related purchase and sale contracts. In addition, the Company from time to time will hedge portions of its anticipated production requirements. The instruments used are principally readily marketable exchange traded futures contracts which are designated as hedges. The changes in market value of such contracts have a high correlation to the price changes of the hedged commodity. Also, the underlying commodity can be delivered against such contracts. To obtain a proper matching of revenue and expense, gains or losses arising from open and closed hedging transactions are included in inventory as a cost of the commodities and reflected in the income statement when the product is sold. Inflation, over time, has an impact on agricultural commodity prices. The Company's business is capital intensive and inflation could impact the cost of capital investment. OPERATIONS Net sales and other operating income decreased 1 percent for the quarter to $3.5 billion due primarily to a 1 percent decrease in volume of products sold. For the nine months, net sales and other operating income increased $381 million to $10.4 billion due principally to a 6 percent increase in average selling prices partially offset by a 2 percent decrease in volume of products sold. A summary of net sales and other operating income by classes of products and services is as follows: THREE MONTHS NINE MONTHS ENDED ENDED MARCH 31, MARCH 31, 1997 1996 1997 1996 _______________ ______________ (In millions) (In millions) Oilseed products $2,244 $2,126 $6,629 $6,055 Corn products 524 647 1,689 1,937 Wheat and other milled 371 416 1,245 1,247 products Other products and 327 298 840 783 services ----- ----- ------ ------ $3,466 $3,487 $10,403 $10,02 2 ===== ===== ====== ====== 11 PAGE 12 Sales of oilseed products increased 6 percent for the quarter due principally to higher sales volumes reflecting strong domestic protein meal and oil demand. For the nine months, sales of oilseed products increased 9 percent due primarily to higher average selling prices reflecting the higher cost of raw materials. Sales of corn products decreased 19 percent for the quarter and 13 percent for the nine months due primarily to decreased sales volumes of fuel alcohol as reduced corn supplies and the resulting higher cost of corn resulted in the Company reducing its production of fuel alcohol. Average selling prices of corn products were up 1 percent for the quarter and 4 percent for the nine months due to the good demand for the Company's fuel alcohol and bioproducts, including lysine and threonine. These average selling price increases were partially offset by lower average selling prices for the Company's sweetener products as a result of the start-up of new corn wet milling facilities and the resulting overcapacity in the market place. Sales of wheat and other milled products decreased 11 percent for the quarter due to both decreased average selling prices and decreased sales volumes reflecting reduced export flour demand and excess milling capacity in the industry. For the nine months, sales of wheat and other milled products were virtually unchanged as a 3 percent increase in average selling prices reflecting the increase in raw material costs was offset by a 3 percent decrease in sales volume reflecting reduced demand and excess milling capacity. The increase in other products and services was due principally from the sales related to the Company's recently acquired cocoa business. Cost of products sold and other operating costs increased $107 million for the quarter to $3.3 billion and increased $483 million for the nine months to $9.4 billion due primarily to increased average raw material commodity prices, increased energy costs and costs related to recently acquired operations. These increases were partially offset by the decrease in volume of products sold. Gross profit declined $128 million to $211 million for the quarter due to the net effect of increased raw material costs versus higher sales prices and decreased merchandising and transportation margins. For the nine months, gross profit declined $102 million to $958 million due to decreased merchandising and transportation margins, decreased sales volumes and the net effect of increased raw material costs versus higher sales prices. Selling, general and administrative expenses decreased $6 million to $115 million for the quarter due primarily to decreased legal and litigation related expenses which were partially offset by $6 million of increases attributable to recently acquired operations. For the nine months, selling, general and administrative expense increased $182 million to $530 million due principally to increased legal and litigation related costs including the $200 million provision made in the first quarter of the fiscal year related to fines and litigation settlements arising out of the United States Department of Justice antitrust investigation of the Company's lysine and citric acid products as well as a securities suit brought by shareholders (see note 4). The decrease in other income for the quarter and nine months was due principally to decreased gains on marketable securities transactions. To a lesser extent, other income decreased for the quarter and nine months due to decreased investment income due to both lower invested funds and lower interest rates, decreased equity in earnings of affiliates and increased interest expense due to both lower amounts of interest capitalized on construction projects and increased levels of borrowing. For the nine months, the decrease in other income reflects the prior year's $15 million gain on the sale of the Company's Supreme Sugar subsidiary. The decrease in income taxes for both the quarter and the nine months resulted primarily from lower pretax earnings. For the nine months, this decrease was partially offset by a higher effective income tax rate. The increase in the Company's effective income tax rate to 44 percent for the nine months compared to an effective rate of 34 percent last year was due primarily to the non-deductibility for income tax purposes of a portion of the Company's litigation settlements and fines. The Company's effective income tax rate of 34 percent for the quarter was comparable to the same period a year ago. LIQUIDITY AND CAPITAL RESOURCES During the nine months ended March 31, 1997, the Company's cash and marketable securities net of short-term debt decreased $1.3 billion to $97 million, working capital decreased $544 million to $2.2 billion and shareholders' equity decreased $120 million to $6 billion. These decreases reflect investments in property, plant and equipment expansions, investments in affiliates, business acquisitions, and purchases of the Company's common stock. During the quarter, the Company issued $350 million of 7.5 percent debentures due in 2027. The Company's ratio of long- term liabilities to total capital at March 31, 1997 was approximately 26 percent. As discussed in Note 4 to the unaudited consolidated financial statements, various grand juries under the direction of the United States Department of Justice have been conducting investigations into possible violations by the Company of federal antitrust laws and related matters with respect to the sale of lysine, citric acid and high fructose corn syrup product lines. Two former executive officers of the Company have been indicted in connection with the lysine investigation. On October 15, 1996, the Company pled guilty to engaging in anticompetitive conduct in connection with the sale of lysine and citric acid and agreed to pay the United States $100 million in fines. The agreement brings to a close all Department of Justice investigations against the Company, including the investigation with respect to high fructose corn syrup. In addition, related civil class actions and other proceedings have been filed against the Company which could result in the Company being subject to monetary damages, other sanctions and expenses. As also discussed in Note 4 to the unaudited consolidated financial statements, the Company has agreed to settle or has settled certain civil class action suits involving lysine antitrust, citric acid antitrust and federal securities law litigation. The Company made a $200 million provision in the quarter ended September 30, 1996 sufficient to cover such fines and settlements and related costs and expenses. Because of the early stage of other putative class actions and proceedings, including those related to high fructose corn syrup, the ultimate outcome and materiality of these matters cannot presently be determined. Accordingly, no provision for any liability that may result therefrom has been made in the unaudited consolidated financial statements. 12 PAGE 13 PART II - OTHER INFORMATION Item 1. Legal Proceedings ENVIRONMENTAL MATTERS In 1993, the State of Illinois Environmental Protection Agency brought administrative enforcement proceedings arising out of the Company's failure to obtain permits for certain pollution control equipment at certain of the Company's processing facilities in Illinois. The Company believes it has meritorious defenses. In management's opinion these proceedings will not, either individually or in the aggregate, have a material adverse effect on the Company's financial condition or results of operations. The Company is involved in approximately 24 administrative and judicial proceedings in which it has been identified as a potentially responsible party (PRP) under the federal Superfund law and its state analogs for the study and clean- up of sites contaminated by material discharged into the environment. In all of these matters, there are numerous PRPs. Due to various factors such as the required level of remediation and participation in the clean-up effort by others, the Company's future clean-up costs at these sites cannot be reasonably estimated. However, in management's opinion these proceedings will not, either individually or in the aggregate, have a material adverse effect on the Company's financial condition or results of operations. LITIGATION REGARDING ALLEGED ANTICOMPETITIVE PRACTICES The Company and certain of its current and former officers and directors are currently defendants in various lawsuits related to alleged anticompetitive practices by the Company as described in more detail below. The Company and the individual defendants named in these actions intend to vigorously defend the actions unless they can be settled on terms deemed acceptable to the parties. The Company has paid and intends to continue to pay the legal expenses of its current and former officers and directors and to indemnify these persons with respect to these actions in accordance with Article X of the Bylaws of the Company. GOVERNMENTAL INVESTIGATIONS A federal grand jury in the Northern District of Illinois has been conducting an investigation into possible violations by the Company of federal antitrust laws and related matters with respect to the sale of lysine, an amino acid feed additive used in poultry and swine feed. A federal grand jury in the Northern District of California has been investigating possible antitrust violations by the Company with respect to the sale of citric acid, an organic acid used in various foods, beverages and other products. A federal grand jury in the Northern District of Georgia has been investigating possible antitrust 13 PAGE 14 violations by the Company with respect to the sale of the Company's high fructose corn syrup product line. Each of these investigations has been under the direction of the United States Department of Justice. Two former executive officers of the Company, Michael D. Andreas and Terrance S. Wilson, have been indicted in connection with the lysine investigation. On October 15, 1996, the Company pled guilty to a two count information in the Northern District of Illinois pursuant to an agreement with the Department of Justice. This information states that the Company engaged in anticompetitive conduct in connection with the sale of lysine and citric acid. In connection with its agreement the Company has paid the United States a fine of $70 million with respect to lysine and $30 million with respect to citric acid. This agreement constitutes a global resolution of all matters between the United States Department of Justice and the Company and brings to a close all Department of Justice investigations of the Company, including the federal grand jury's investigation with respect to high fructose corn syrup. The Company's agreement with the Department of Justice further obligates the Company to cooperate with the government's continued investigation with respect to possible violations by others of federal antitrust laws and related matters in the food additives industry. Under the agreement, the Department of Justice agrees not to bring any action against any director, officer or employee of the Company (or its subsidiaries or affiliates), other than Michael D. Andreas and Terrance S. Wilson, involving the sale or production of any product sold or produced by the Company's BioProducts Division, Animal Health and Nutrition Division, Food Additives Division, or Sweetener Group or for any action which was or is the subject of pending investigations in the Central District of Illinois and the Southern District of Alabama. Mr. Andreas, who no longer serves as an officer of the Company, requested and was granted a temporary administrative leave from the Company. Mr. Wilson has retired from the Company for medical reasons. There is no understanding or agreement as to what position, if any, Mr. Andreas may return to at the Company. As part of the agreement, the United States agreed not to bring further criminal charges against the Company or any of its subsidiaries or affiliates for any offense committed prior to the date of the agreement that was undertaken in furtherance of or in connection with any attempted or completed antitrust conspiracy involving the sale or production of any product by the Company's BioProducts Division, Animal Health and Nutrition Division, Food Additives Division, or Sweetener Group, or for any alleged offense which is or was the subject of any pending investigation of ADM. Although the immunity agreement excepted any criminal violations of the federal tax law from its scope, the agreement represented that ADM was not a subject of the investigation being conducted by the Fraud Section of the Criminal Division of the Department of Justice. The government further agreed not to prosecute any current officer, director, or employee of the Company or any of its subsidiaries or affiliates (other than Michael D. Andreas and Terrance S. Wilson) for any of the antitrust matters set forth above or for any alleged misappropriation of technology committed prior to the date of the agreement. The Company also agreed to cooperate with the government's investigations by: (i) providing non-privileged documents, information, and other materials; and (ii) securing, using its best efforts, the cooperation of any current director, officer, or employee of the Company or its subsidiaries or affiliates (other than Michael D. Andreas and Terrance S. Wilson) for service of process, interviews, grand jury testimony, and trial testimony. The agreement also provided that if any current officer, director or employee failed to comply with the cooperation obligations as specified, the agreement not to prosecute those persons would be void. The full details of the plea agreement and the Company's cooperation obligations thereunder are set forth in the agreement, which is a matter of public record in 96-CR- 00640. On February 12, 1997 the Company's three Mexican subsidiaries each received notice that the Mexican Federal Competition Commission has commenced an investigation in order to determine if, as a result of the Company's guilty plea in the United States, violations of the Mexican Federal Anti-trust Law have been committed relative to the marketing and sale of lysine in Mexico. SECURITIES LAWS CLASS ACTION Following public announcement in June 1995 of the government's antitrust investigation, the Company and certain of its then current directors and executive officers were named as defendants in seventeen putative class action suits filed on behalf of all purchasers of securities of the Company during the period between certain dates in 1992 and 1995. Fourteen of these suits were consolidated under the name In Re Archer-Daniels-Midland Company Securities Litigation, United States District Court, Northern District of Illinois, Civil Action No. 95-C- 3979, and a consolidated complaint was filed on September 22, 1995. The consolidated complaint alleged that the defendants made material misrepresentations and omissions with respect to the Company and its operations and with respect to actions of the Company and its officers regarding antitrust violations, as a result of which market prices of the Company's securities were artificially inflated during the putative class period. The consolidated complaint alleged that the conduct complained of violates federal securities laws. The plaintiffs requested unspecified compensatory damages, costs (including attorneys and expert fees), expenses and other unspecified relief on behalf of the putative class. On October 31, 1995, the Court granted the defendants' motion to transfer the consolidated action to the Central District of Illinois (wherein it bore the caption E. M. Lawrence Limited Frozen Retirement Trust Dated September 1, 1992, et al. v. Archer- Daniels-Midland Co., et al., Case Number 95-2287). The three remaining actions, which originally were filed in the Central District of Illinois, also were consolidated as part of the E.M. Lawrence Limited Frozen Retirement Trust Dated September 1, 1992, et al. v. Archer Daniels Midland Co., et al., action. The Company and the individual defendants moved to dismiss this consolidated action. 14 PAGE 15 On September 27, 1996, the Company entered into an agreement with counsel for the plaintiff class in which among other things, the Company agreed to pay $30 million to members of the class, without admitting the alleged violations of law. On April 11, 1997, the court granted final approval of this settlement and the time for filing an appeal has expired. HIGH FRUCTOSE CORN SYRUP ACTIONS The Company, along with other companies, has been named as a defendant in thirty antitrust suits involving the sale of high fructose corn syrup. Twenty-nine of these actions have been brought as putative class actions. FEDERAL ACTIONS. Twenty-two of these putative class actions allege violations of federal antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup, and seek injunctions against continued alleged illegal conduct, treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative classes in these cases comprise certain direct purchasers of high fructose corn syrup during certain periods in the 1990s. These twenty-two actions have been transferred to the United States District Court for the Central District of Illinois and consolidated under the caption In Re High Fructose Corn Syrup Antitrust Litigation, MDL No. 1087 and Master File No. 95-1477. The parties are in the midst of discovery in this action. On January 14, 1997, the Company, along with other companies, was named a defendant in a non-class action antitrust suit involving the sale of high fructose corn syrup and corn syrup. This action which is encaptioned Gray & Co. v. Archer Daniels Midland Co., et al, No. 97-69- AS and was filed in federal court in Oregon, alleges violations of federal antitrust laws and Oregon and Michigan state antitrust laws, including allegations that defendants conspired to fix, raise, maintain and stabilize the price of corn syrup and high fructose corn syrup, and seeks treble damages, attorneys' fees and costs of an unspecified amount. The Company has not yet filed a responsive pleading. STATE ACTIONS. The Company, along with other companies, also has been named as a defendant in six putative class action antitrust suits filed in California state court involving the sale of high fructose corn syrup. These California actions allege violations of the California antitrust and unfair competition laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup, and seek treble damages of an unspecified amount, attorneys fees and costs, restitution and other unspecified relief. One of the California putative classes comprise certain direct purchasers of high fructose corn syrup in the State of California during certain periods in the 1990s. This action was filed on October 17, 1995 in Superior Court for the County of Stanislaus, California and encaptioned Kagome Foods, Inc. v Archer-Daniels-Midland Co. et al., Civil Action No. 37236. This action has been removed to federal court and consolidated with the federal class action litigation pending in the Central District of Illinois referred to above. The other five California putative classes comprise certain indirect purchasers of high fructose corn syrup and dextrose in the State of California during certain periods in the 1990s. One such action was filed on July 21, 1995 in the Superior Court of the County of Los Angeles, California and is encaptioned Borgeson v. Archer-Daniels-Midland Co., et al., Civil Action No. BC131940. This action and the other four indirect purchases actions have been coordinated before a single court in Stanislaus County, California under the caption, Food Additives (HFCS) cases, Master File No. 39693. The other four actions are encaptioned, Goings v. Archer Daniels Midland Co., et al., Civil Action No. 750276 (Filed on July 21, 1995, Orange County Superior Court); Rainbow Acres v. Archer Daniels Midland Co., et al., Civil Action No. 974271 (Filed on November 22, 1995, San Francisco County Superior Court); Patane v. Archer Daniels Midland Co., et al., Civil Action No. 212610 (Filed on January 17, 1996, Sonoma County Superior Court); and St. Stan's Brewing Co. v. Archer Daniels Midland Co., et al., Civil Action No. 37237 (Filed on October 17, 1995, Stanislaus County Superior Court). The Company, along with other companies, also has been named a defendant in a putative class action antitrust suit filed in Alabama state court. The Alabama action alleges violations of the Alabama, Michigan and Minnesota antitrust laws, including allegations that defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup, and seeks an injunction against continued illegal conduct, damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in the Alabama action comprises certain indirect purchasers in Alabama, Michigan and Minnesota during the period March 18, 1994 to March 18, 1996. This action was filed on March 18, 1996 in the Circuit Court of Coosa County, Alabama, and is encaptioned Caldwell v. Archer-Daniels-Midland Co., et al., Civil Action No. 96-17. On April 23, 1997, the court granted the defendants' motion to sever and dismiss the non- Alabama claims. LYSINE CLASS ACTION The Company, along with other companies, has been named as a defendant in twenty-one putative class action antitrust suits involving the sale of lysine. FEDERAL ACTIONS. Six of these actions allege violations of federal antitrust laws, including allegations that certain entities agreed to fix, stabilize and maintain at artificially high levels the price of lysine, and seek injunctions against continued alleged illegal conduct, treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative classes in these cases comprise certain direct purchasers of lysine for certain periods in the 1990s. These six actions were transferred to the United States District Court for the Northern District of Illinois and consolidated under the caption In Re Amino Acid Lysine Antitrust Litigation, MDL No. 1083 and Master File No. 95-7679. On April 4, 15 PAGE 16 1996, the Company executed a settlement agreement with counsel for the plaintiff class in which, among other things, the Company agreed to pay $25 million to members of the class, without admitting the alleged violations of law. Several plaintiffs opted out of this settlement. This settlement agreement was approved by the court and certain objectors to the settlement appealed the final order of approval to the United States Court of Appeals for the Seventh Circuit. That appeal subsequently was dismissed. The Company, along with other companies also was named as a defendant in one non-class action federal antitrust suit involving the sale of lysine. This action was filed on November 13, 1995 in the United States District Court for the Eastern District of Missouri and is encaptioned Purina Mills, Inc., et al. v Archer-Daniels-Midland Co., Civil Action No. 95-CV-2227. It alleged violations of federal antitrust laws, including allegations that certain entities agreed to fix, stabilize and maintain at artificially high levels the price of lysine, and seeks an injunction against continued alleged illegal conduct, treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. This action was subsequently consolidated with In Re Amino Acid Lysine Antitrust Litigation and the Company settled this action, which included plaintiffs who opted out of or objected to the settlement noted above, for an amount deemed not material. The Company, along with other companies, also was named a defendant in a nationwide federal class action brought on behalf of consumers of certain poultry products during the period 1992 through 1996. This action alleged violations of the federal antitrust laws, including allegations that the defendants unlawfully fixed the price of lysine, and requests $300 million in treble damages. On January 17, 1997, the court dismissed the action without prejudice after plaintiff requested a voluntary dismissal. This action was encaptioned Silvious v. Archer-Daniels-Midland Co., et al., No. 96-0128(H) and was filed on November 18, 1996 in federal court in the Western District of Virginia. STATE ACTIONS. The Company also has been named as a defendant, along with other companies, in six putative class action antitrust suits filed in California state court, two putative class action antitrust suits and one non-class action suit filed in Alabama state court, two putative class action antitrust suits filed in Minnesota state court, one putative class action antitrust suit filed in Georgia state court, one putative class action antitrust suit filed in Tennessee state court and two putative class action antitrust suits filed in Michigan state court involving the sale of lysine. The California actions allege violations of the California antitrust and unfair competition laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of lysine, and seek treble damages of an unspecified amount, attorneys fees and costs, restitution and other unspecified relief. The putative classes in the California actions comprise certain indirect purchasers of lysine in the State of California during certain periods in the 1990s. These six actions were consolidated before the Superior Court for San Francisco County under the caption Feedstuffs Processing Co. v. Archer Daniels Midland Co, et al., Case No. 974597. The Company entered into an agreement with plaintiffs' counsel in these California actions, in which among other things, the Company agreed to pay $500,000 to certain members of the class, without admitting the alleged violations of law. This settlement has received final court approval. The two putative Alabama class actions allege violations of the Alabama antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of lysine, and seek an injunction against continued alleged illegal conduct, damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The two putative classes in the Alabama actions comprise certain indirect purchasers of lysine in the State of Alabama during certain periods in the 1990s. One such action was filed on August 17, 1995 in the Circuit Court of DeKalb County, Alabama, and is encaptioned Ashley v. Archer-Daniels-Midland Co., et al., Civil Action No. 95- 336. The parties are in the midst of discovery in this action. The other Alabama action, encaptioned Bailey v. Archer Daniels Midland Co., et al., Civil Action No. 95- 165, and filed on December 11, 1995 in the Circuit Court of Tallapoosa County, has been placed on the court's administrative docket pending the outcome of the Ashley action. The non-class action, encaptioned Kent v. Archer Daniels Midland Co., et al, No. CV 9701108, and filed on February 21, 1997 in the Circuit Court of Jefferson County, Alabama, includes allegations that are similar to these contained in the putative class actions and seeks monetary relief in the amount of $670,000, injunctive relief against alleged illegal conduct, attorneys fees and costs, punitive damages and other unspecified relief. One Minnesota action alleges violations of certain laws of the states of Minnesota, Tennessee, Wisconsin, South Dakota, North Dakota, Kansas, Louisiana, Michigan, Maine, Arizona, Florida, Mississippi, New Mexico, North Carolina and West Virginia, and the District of Columbia, including allegations that defendants conspired to maintain the price of lysine at artificially high levels, and seeks treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in this action comprises certain indirect purchasers in the aforementioned states of lysine during the period June 1, 1992 through April 19, 1996. This action was filed on April 10, 1996 in the District Court for Renville County, Minnesota and is encaptioned Big Valley Milling, Inc. v. Archer-Daniels-Midland Co., et al., No. C7-96-260. The other Minnesota action, encaptioned, United Mills v. Archer- Daniels-Midland Co., et al., No. 65-C2-96-215, and filed in the same court, seeks identical relief on behalf of certain indirect purchasers of lysine in all of the aforementioned states. On September 30, 1996, the Company moved to dismiss the non-Minnesota claims in the two Minnesota actions and moved for summary judgment on all claims in these actions. That motion is currently pending. On February 5, 1997, the Company entered into an agreement with plaintiffs' counsel in the Minnesota actions, in which among other things, the Company agreed to pay $1 million to certain members of the putative classes, without admitting the alleged violations of law. 16 PAGE 17 This settlement received preliminary court approval and a final approval hearing is set for July 1997. The Georgia action, encaptioned Long v. Archer-Daniels-Midland Co., et al., Civil Action No. E-43829, and filed on December 13, 1995 in Fulton County Superior Court, alleges a restraint of trade in violation of Georgia common law and the Georgia state RICO act. This action includes allegations that the defendants conspired to maintain the price of lysine at artificially high levels and seeks an injunction against continued illegal conduct, treble damages of an unspecified amount, punitive damages attorneys fees and costs, and other unspecified relief. The putative class in the action comprises certain indirect purchasers of lysine in the state of Georgia during the period January 1, 1990 until the present. On December 19, 1996, the Court granted the Company's motion to dismiss this action. The Tennessee action, encaptioned McCormack Farms v. Archer Daniels Midland Co., et al., Civil Action No. 96C-2190, and filed on June 11, 1996 in Davidson County Circuit Court, alleges a restraint of trade in violation of the Tennessee Trade Practices Act and Tennessee Consumer Protection Act. This action includes allegations that defendants conspired to fix, maintain or stabilize the prices of lysine and seeks an injunction against continued illegal conduct, treble damages of an unspecified amount, attorneys' fees and costs, and other unspecified relief. The putative class in this case comprises certain indirect purchasers of lysine within the State of Tennessee during the period June 10, 1992 through June 10, 1996. The Company has not yet filed a responsive pleading. The Michigan actions allege a restraint of trade in violation of the Michigan Antitrust Reform Act and include allegations that defendants conspired to fix, raise, maintain and stabilize the price of lysine and seeks an injunction against continued illegal conduct, treble damages of an unspecified amount, attorneys' fees and costs, and other unspecified relief. The putative classes in these cases comprise certain indirect purchasers of lysine within the State of Michigan during certain periods in the 1990s. One such action, encaptioned Michigan Pork Producers Assn, et al. v. Archer Daniels Midland Co., et al., No. 906-10696-CZ, was filed on September 25, 1996 in Kent County Circuit Court. The Company has not yet filed a responsive pleading in either action. The second action, encaptioned Bacon Acres v. Archer Daniels Midland Co., et al., No P23920, was filed on September 24, 1996 in the Circuit Court for the County of Washtenaw, Michigan. On April 25, 1997, plaintiffs voluntarily dismissed this action. CITRIC ACID CLASS ACTIONS The Company, along with other companies, has been named as a defendant in eleven putative class action antitrust suits involving the sale of citric acid. FEDERAL ACTIONS. Seven of these actions allege violations of federal antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of citric acid, and seek injunctions against continued alleged illegal conduct, treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative classes in these cases comprise certain direct purchasers of citric acid for certain periods in the 1990s. These six actions have been transferred to the United States District Court for the Northern District of California and consolidated as In Re Citric Acid Antitrust Litigation, MDL No. 1092, Master File No. C-95-2963(FMS). On September 27, 1996 the Company entered into an agreement with counsel for the plaintiff class in this consolidated action in which among other things, the Company agreed to pay $35 million to members of the class, without admitting the alleged violations of law. On March 3, 1997, the court preliminarily approved the settlement and a final approval hearing is set for July 11, 1997 Under the terms of the settlement agreement, the Company has the right to rescind the agreement if plaintiffs elect to opt out of the class and those plaintiffs have combined citric acid purchases from the Company during the class period that exceed 25% of the Company's total citric acid sales during such period. Based on the opt out notices that the Company is aware of to date, the Company may, at its option, rescind the settlement agreement on or before May 19, 1997. On February 4, 1997, a class action complaint, encaptioned Galavan Supplements Ltd. v. Archer Daniels Midland Co., et al., No. 97-0704 JGD (VAPx), was filed in the United States District Court for the Central District of California. The Company, along with other companies, was named a defendant in this putative class action brought on behalf of a class consisting of all persons and entities outside of the United States who purchased citric acid directly from any defendants through their foreign facilities during the time period July 1, 1991 through June 30, 1995. This action alleges violations of the federal antitrust laws, including allegations that the defendants conspired to fix, maintain and stabilize the price of citric acid and to allocate amongst themselves their major citric acid customers, accounts and market shares on a worldwide basis. The Company has not yet filed a responsive pleading in this action. STATE ACTIONS. The Company, along with other companies, also has been named as a defendant in one putative class action antitrust suit filed in Alabama state court involving the sale of citric acid. This action alleges violations of the Alabama antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of citric acid, and seeks an injunction against continued alleged illegal conduct, damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in the Alabama action comprises certain indirect purchasers of citric acid in the State of Alabama from July 1993 until July 1995. This action was filed on July 27, 1995 in the Circuit Court of Walker County, Alabama and is encaptioned Seven Up Bottling Co. of Jasper, Inc. v. Archer-Daniels-Midland Co., et al., Civil Action No. 95-436. The Company currently is seeking appellate review of the denial of its motion to dismiss this action. The Company, along with other companies, also has been named as a defendant in two putative class action antitrust suits filed in California state court involving the sale of citric acid. These actions allege violations of the California antitrust and unfair competition laws, including allegations that the defendants conspired to fix, maintain or stabilize the price of citric acid, and seek injunctions against continued illegal conduct, treble damages of an unspecified amount, attorneys fees and costs, and other unspecified 17 PAGE 18 relief. The putative classes in these cases comprise certain indirect purchasers of citric acid within the State of California during certain periods in the 1990s. One such action was filed on June 12, 1996 in the Superior Court of the County of San Francisco, California and is encaptioned Bianco v. Archer Daniels Midland Co., et al., Civil Action No. 978912. The second action was filed on June 28, 1996 in San Francisco County Superior Court and is encaptioned Wignall v. Archer Daniels Midland Co., et al., Civil Action No. 979360. These actions recently have been coordinated before a single court in San Francisco, County, California under the caption, Food Additives (Lysine/Citric Acid) cases, Coordination Proceeding No. 3265. The Company, along with other companies, also has been named as a defendant in one putative class action antitrust suit filed in Wisconsin state court involving the sale of citric acid. This action alleges violations of the laws of Wisconsin, Minnesota, Alabama, Arizona, California, District of Columbia, Florida, Tennessee, West Virginia, Mississippi New Mexico, North Carolina, South Dakota, North Dakota, Kansas, Louisiana, Michigan and Maine, including allegations that defendants conspired to maintain the price of citric acid at artificially high levels and seeks injunctive relief, treble damages of an unspecified amount, attorneys fees and costs and other unspecified relief. The putative class in this case comprises certain indirect purchasers of citric acid in the above referenced states during the period July 1, 1991 through June 27, 1995. This action was filed on December 20, 1996 in the Circuit Court for Milwaukee County, Wisconsin and is encaptioned Raz, et al. v. Archer-Daniels-Midland Co., et al., No.[96-CV-9729. HIGH FRUCTOSE CORN SYRUP/CITRIC ACID STATE CLASS ACTIONS The Company, along with other companies, has been named as a defendant in six putative class action antitrust suits involving the sale of both high fructose corn syrup and citric acid. Two of these actions allege violations of the California antitrust and unfair competition laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup and citric acid, and seek treble damages of an unspecified amount, attorneys fees and costs, restitution and other unspecified relief. The putative class in one of these California cases comprises certain direct purchasers of high fructose corn syrup and citric acid in the State of California during the period January 1, 1992 until at least October 1995. This action was filed on October 11, 1995 in the Superior Court of Stanislaus County, California and is entitled Gangi Bros. Packing Co. v. Archer-Daniels-Midland Co., et al., Civil Action No. 37217. The putative class in the other California case comprises certain indirect purchasers of high fructose corn syrup and citric acid in the state of California during the period October 12, 1991 until November 20, 1995. This action was filed on November 20, 1995 in the Superior Court of San Francisco County and is encaptioned MCFH, Inc. v. Archer-Daniels-Midland Co., et al., Civil Action No. 974120. The California Judicial Council has bifurcated the citric acid and high fructose corn syrup claims in these actions and coordinated them with other actions in San Francisco County Superior Court and Stanislaus County Superior Court. The Company, along with other companies, also has been named as a defendant in at least one putative class action antitrust suit filed in West Virginia state court involving the sale of high fructose corn syrup and citric acid. This action also alleges violations of the West Virginia antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup and citric acid, and seeks treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in the West Virginia action comprises certain entities within the State of West Virginia that purchased products containing high fructose corn syrup and/or citric acid for resale from at least 1992 until 1994. This action was filed on October 26, 1995, in the Circuit Court for Boone County, West Virginia, and is encaptioned Freda's v. Archer-Daniels-Midland Co., et al., Civil Action No. 95-C-125. The parties are in the midst of discovery in this action. The Company, along with other companies, also has been named as defendant in a putative class action antitrust suit filed in Michigan state court involving the sale of high fructose corn syrup and citric acid. This action alleges violations of the Michigan antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup and citric acid, and seeks treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in the Michigan action comprises certain persons within the State of Michigan that purchased products containing high fructose corn syrup and/or citric acid during the period January 1993 through June 27, 1995. This action was filed on February 26, 1996 in the Circuit Court for Ingham County, Michigan, and is encaptioned Wilcox v. Archer-Daniels-Midland Co., et al., Civil Action No. 96-82473-CP. The parties are in the midst of discovery in this action. The Company, along with other companies, also has been named as a defendant in a putative class action antitrust suit filed in the Superior Court for the District of Columbia involving the sale of high fructose corn syrup and citric acid. This action alleges violations of the District of Columbia antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup and citric acid, and seeks treble damages of an unspecified amount, attorneys fees and costs, and other unspecified relief. The putative class in the District of Columbia action comprises certain persons within the District of Columbia that purchased products containing high fructose corn syrup and/or citric acid during the period January 1, 1992 through December 31, 1994. This action was filed on April 12, 1996 in the Superior Court for the District of Columbia, and is encaptioned Holder v. Archer-Daniels-Midland Co., et al., Civil Action No. 96-2975. The parties are in the midst of discovery in this action. The Company, along with other companies, has been named as a defendant in at least one putative class action antitrust suit filed in Kansas state court involving the sale of high fructose corn syrup and citric acid. This action alleges violations of the Kansas antitrust laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup and citric acid, and seeks treble damages of an unspecified amount, court costs and other unspecified relief. The 18 PAGE 19 putative class in the Kansas action comprises certain persons within the State of Kansas that purchased products containing high fructose corn syrup and/or citric acid during at least the period January 1, 1992 through December 31, 1994. This action was filed on May 7, 1996 in the District Court of Wyandotte County, Kansas and is encaptioned Waugh v. Archer-Daniels-Midland Co., et al., Case No. 96-C-2029. The parties are in the midst of discovery in this action. HIGH FRUCTOSE CORN SYRUP/CITRIC ACID/LYSINE STATE CLASS ACTIONS The Company, along with other companies, has been named as a defendant in six putative class action antitrust suits filed in California state court involving the sale of high fructose corn syrup, citric acid and/or lysine. These actions allege violations of the California antitrust and unfair competition laws, including allegations that the defendants agreed to fix, stabilize and maintain at artificially high levels the prices of high fructose corn syrup, citric acid and/or lysine, and seek treble damages of an unspecified amount, attorneys fees and costs, restitution and other unspecified relief. One of the putative classes comprises certain direct purchasers of high fructose corn syrup, citric acid and/or lysine in the State of California during a certain period in the 1990s. This action was filed on December 18, 1995 in the Superior Court for Stanislaus County, California and is encaptioned Nu Laid Foods, Inc. v. Archer-Daniels-Midland Co., et al., Civil Action No. 39693. The other five putative classes comprise certain indirect purchasers of high fructose corn syrup, citric acid and/or lysine in the State of California during certain periods in the 1990s. One such action was filed on December 14, 1995 in the Superior Court for Stanislaus County, California and is encaptioned Batson v. Archer-Daniels-Midland Co., et al., Civil Action No. 39680. The other actions are encaptioned Nu Laid Foods, Inc. v. Archer Daniels Midland Co., et al., No 39693 (Filed on December 18, 1995 Stanislaus County Superior Court); Abbott v. Archer Daniels Midland Co., et al., No. 41014 (Filed on December 21, 1995, Stanislaus County Superior Court); Noldin v. Archer Daniels Midland Co., et al., No. 41015 (Filed on December 21, 1995, Stanislaus County Superior Court); Guzman v. Archer Daniels Midland Co., et al., No. 41013 (Filed on December 21, 1995, Stanislaus County Superior Court) and Ricci v. Archer Daniels Midland Co., et al., No. 96-AS-00383 (Filed on February 6, 1996, Sacramento County Superior Court). As noted above, the plaintiffs in these actions and the lysine defendants have executed a settlement agreement that has been approved by the court and the California Judicial Council has bifurcated the citric acid and high fructose corn syrup claims and coordinated them with other actions in San Francisco County Superior Court and Stanislaus County Superior Court. SHAREHOLDER DERIVATIVE ACTIONS Following the public announcement of the grand jury investigation in June 1995, three shareholder derivative suits were filed against certain of the Company's then current directors and executive officers and nominally against the Company in the United States District Court for the Northern District of Illinois and fourteen similar shareholder derivative suits were filed in the Delaware Court of Chancery. The derivative suits filed in federal court in Illinois were consolidated under the name Felzen, et al. v. Andreas, et al., Civil Action No. 95-C-4006, 95-C- 4535, and a consolidated amended derivative complaint was filed on September 29, 1995. This complaint names all then current directors of the Company (except Mr. Coan) and one former director as defendants and names the Company as a nominal defendant. It alleges breach of fiduciary duty, waste of corporate assets, abuse of control and gross mismanagement, based on the antitrust allegations described above, as well as other alleged wrongdoing. On October 31, 1995, the Court granted the defendants' motion to transfer the Illinois consolidated derivative action to the Central District of Illinois, wherein it now bears the case number 95-2279. On April 26, 1996, the court dismissed the suit without prejudice and permitted the plaintiffs twenty-one days to refile it. The plaintiffs refiled the complaint on May 17, 1996. The defendants again moved to dismiss the complaint on June 7, 1996. That motion is currently pending. Plaintiffs have supplemented the complaint to include the antitrust settlements and guilty plea described above. The fourteen shareholder derivative suits filed in the Delaware Court of Chancery have been consolidated as In Re Archer Daniels Midland Derivative Litigation, Consolidated No. 14403. An amended and consolidated complaint was filed on November 19, 1996. ADM moved to dismiss the complaint on December 12, 1996. That motion is currently pending. DELAWARE STATE LAW/FEDERAL SECURITIES LAWS ACTIONS The Company and certain of its current and former directors also have been named as defendants in a putative class action suit encaptioned Loudon v. Archer-Daniels- Midland Co., et al., Civil Action No. 14638, filed in the Delaware Court of Chancery on October 20, 1995. This action alleges violations of Delaware state law and seeks invalidation of the 1995 election of the Company's directors on the basis of alleged omissions from the proxy statement issued by the Company prior to its October 19, 1995 annual meeting of shareholders. The Delaware Court of Chancery dismissed this action on February 20, 1996, and the case is now on appeal in the Supreme Court of Delaware. The Company and certain of its current and former directors also have been named as defendants in a similar suit filed on November 1, 1995 in the United States District Court for the Central District of Illinois, and encaptioned Buckley v. Archer-Daniels-Midland Co., et al., Civil Action No. 95-C-2269, alleging violations of analogous provisions of federal securities law. The defendants moved to dismiss this action. The Court granted the motion to dismiss on June 6, 1996, and the Court of Appeals for the Seventh Circuit recently dismissed an appeal of the lower court's dismissal on the grounds that the appeal had been rendered moot by the 1996 board election. As described in the notes to financial statements and management's discussion of operations in prior Form 10-Q's, the Company has made provisions to cover assessed fines, litigation settlements and related costs and expenses described above. However, because of the early stage of other putative class actions and proceedings described above, including those related to high fructose corn syrup, the ultimate outcome and materiality of these matters cannot presently be determined. Accordingly, no provision for any liability that may result therefrom has been made in the consolidated financial statements. Item 6. Exhibits and Reports on Form 8-K a) A Form 8-K was not filed during the quarter ended March 31, 1997. 19 PAGE 20 SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ARCHER-DANIELS-MIDLAND COMPANY /s/ D. J. Schmalz D. J. Schmalz Vice President and Chief Financial Officer /s/ R. P. Reising R. P. Reising Vice President, Secretary and General Counsel Dated: May 15, 1997 20